Title : Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation.

Pub. Date : 2018 Nov

PMID : 30221728






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pristimerin and paclitaxel inhibited extracellular signal-regulated kinase (ERK)1/2/p90RSK signaling, consistent with autophagy indicators, namely p62 degradation and beclin 1 expression. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
2 In addition, ERK activator ceramide C6 treatment suppressed the LC3-II levels induced by a combination of paclitaxel and pristimerin. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens
3 These results suggested that exposure to pristimerin induced autophagic cell death, whereas a combination treatment of pristimerin and paclitaxel resulted in an additive effect on ERK-dependent autophagic cell death. Paclitaxel mitogen-activated protein kinase 1 Homo sapiens